NeuroSense Therapeutics Analyst Ratings
NeuroSense Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/17/2023 | 435.71% | Alliance Global Partners | → $7.5 | Initiates Coverage On | → Buy |
| 01/07/2022 | 400% | Maxim Group | → $7 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 07/17/2023 | 435.71% | 联盟全球合作伙伴 | → 7.5 美元 | 启动覆盖开启 | → 购买 |
| 01/07/2022 | 400% | Maxim 集团 | → 7 美元 | 启动覆盖开启 | → 购买 |
What is the target price for NeuroSense Therapeutics (NRSN)?
NeuroSense Therapeutics（NRSN）的目标价格是多少？
The latest price target for NeuroSense Therapeutics (NASDAQ: NRSN) was reported by Alliance Global Partners on July 17, 2023. The analyst firm set a price target for $7.50 expecting NRSN to rise to within 12 months (a possible 435.71% upside). 1 analyst firms have reported ratings in the last year.
联盟全球合作伙伴于2023年7月17日公布了NeuroSense Therapeutics（纳斯达克股票代码：NRSN）的最新目标股价。这家分析公司将目标股价定为7.50美元，预计NRSN将在12个月内升至435.71％（可能上涨435.71％）。去年有1家分析公司公布了评级。
What is the most recent analyst rating for NeuroSense Therapeutics (NRSN)?
分析师对NeuroSense Therapeutics（NRSN）的最新评级是多少？
The latest analyst rating for NeuroSense Therapeutics (NASDAQ: NRSN) was provided by Alliance Global Partners, and NeuroSense Therapeutics initiated their buy rating.
NeuroSense Therapeutics（纳斯达克股票代码：NRSN）的最新分析师评级由联盟全球合作伙伴提供，NeuroSense Therapeutics启动了买入评级。
When is the next analyst rating going to be posted or updated for NeuroSense Therapeutics (NRSN)?
NeuroSense Therapeutics（NRSN）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NeuroSense Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NeuroSense Therapeutics was filed on July 17, 2023 so you should expect the next rating to be made available sometime around July 17, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与NeuroSense Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。NeuroSense Therapeutics的最后一次评级是在2023年7月17日提交的，因此你应该预计下一个评级将在2024年7月17日左右公布。
Is the Analyst Rating NeuroSense Therapeutics (NRSN) correct?
分析师对 NeuroSense Therapeutics (NRSN) 的评级是否
While ratings are subjective and will change, the latest NeuroSense Therapeutics (NRSN) rating was a initiated with a price target of $0.00 to $7.50. The current price NeuroSense Therapeutics (NRSN) is trading at is $1.40, which is within the analyst's predicted range.
虽然评级是主观的，会发生变化，但最新的NeuroSense Therapeutics（NRSN）评级是最初的，目标股价为0.00美元至7.50美元。NeuroSense Therapeutics（NRSN）目前的交易价格为1.40美元，在分析师的预测区间内。